Danaparoid is a heparinoid anticoagulant and antithrombotic agent composed of a mixture of glycosaminoglycans, including heparan sulfate, dermatan sulfate, and chondroitin sulfate. It is primarily indicated… Read more
Danaparoid is a heparinoid anticoagulant and antithrombotic agent composed of a mixture of glycosaminoglycans, including heparan sulfate, dermatan sulfate, and chondroitin sulfate. It is primarily indicated for the prophylaxis of deep venous thrombosis in high-risk surgical settings and as a treatment for patients with heparin-induced thrombocytopenia. To support the rigorous analytical testing and quality control required for this drug substance, pharmaceutical laboratories utilize highly characterized reference standards. This category includes Danaparoid API reference materials alongside related non-pharmacopeial impurities and stable isotope-labelled compounds. These critical tools are essential for impurity profiling, method validation, and precise quantification during bioanalytical studies. By providing reliable benchmarks for detecting trace degradants and verifying product consistency, these standards help ensure compliance with regulatory expectations and support the maintenance of drug safety and efficacy throughout the development lifecycle.